FRIULCHEM S.P.A. Euronext Growth
Conference
May 24, 2022
Today's speakers
Disma Giovanni | Carlo |
Mazzola | Marelli |
CEO & Investor | CFO |
Relations |
2
Agenda
- Company Overview
- Market Vet & Human
- BU Vet & Human
- Strategic Guidelines
- Achievements
- Financials FY2021
- Appendix
3
Company Overview
4
Friulchem at a glance
Leading Italian operator active at an international level in R&D and in the production for third party of semi-finished and finished products containing active pharmaceutical ingredients and food supplements.
Specialization in:
- drug delivery for the Veterinary sector - BU VET
- development of dossiers for generic drugs in the Human sector - BU Human
Listed at the EGM since July 2019.
Headquartered in Milan with the production plants located in the industrial area of Vivaro (Friuli Venezia Giulia) and in Magny-en-Vexin (France).
FY2021 CONSOLIDATED FINANCIAL HIGHLIGHTS | MAIN CLIENTS | |||||||
Value of Production | Vet € 16.3 million | |||||||
€ 24.5 million | Human € 6.6 million | |||||||
EBITDA | EBITDA Margin | NFP | ||||||
€ 1.6 million | 6.4 % | € 3.1 million | ||||||
5
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Friulchem S.p.A. published this content on 24 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 May 2022 09:07:05 UTC.
